Back to top
more

DaVita (DVA)

(Delayed Data from NYSE)

$161.97 USD

161.97
575,208

+1.87 (1.17%)

Updated Oct 18, 2024 04:00 PM ET

After-Market: $161.95 -0.02 (-0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth D Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 6% (15 out of 250)

Industry: Medical - Outpatient and Home Healthcare

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Is DaVita (DVA) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research

Is (DVA) Outperforming Other Medical Stocks This Year?

Here's Why You Should Retain DaVita in Your Portfolio Now

by Zacks Equity Research

Investor confidence is high on DaVita (DVA), thanks to solid prospects.

Here's Why You Should Retain VEEVA Systems (VEEV) Stock Now

by Zacks Equity Research

Investor confidence is high in VEEVA Systems (VEEV), thanks to solid prospects.

    DVA vs. CHE: Which Stock Is the Better Value Option?

    by Zacks Equity Research

    DVA vs. CHE: Which Stock Is the Better Value Option?

    Has DaVita (DVA) Outpaced Other Medical Stocks This Year?

    by Zacks Equity Research

    Is (DVA) Outperforming Other Medical Stocks This Year?

    Surmodics Gets CE Mark for SurVeil Drug-Coated Balloon

    by Zacks Equity Research

    Surmodics' (SRDX) receipt of CE Mark for SurVeil DCB should boost the company's Medical Devices segment.

      DexCom's (DXCM) G6 CGM System Gets CE Marking in Europe

      by Zacks Equity Research

      DexCom (DXCM) announces the receipt of CE Marking across Europe for its G6 CGM System.

      Urmimala Biswas headshot

      5 Coronavirus-Proof PEG Picks Suitable for GARP Investors

      by Urmimala Biswas

      PEG-based investing can be more rewarding with the addition of a few other relevant parameters amid coronavirus-led market rattle.

      Is DaVita HealthCare (DVA) a Great Value Stock Right Now?

      by Zacks Equity Research

      Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

      DVA or CHE: Which Is the Better Value Stock Right Now?

      by Zacks Equity Research

      DVA vs. CHE: Which Stock Is the Better Value Option?

      Is DaVita (DVA) Outperforming Other Medical Stocks This Year?

      by Zacks Equity Research

      Is (DVA) Outperforming Other Medical Stocks This Year?

      Should Value Investors Buy DaVita HealthCare (DVA) Stock?

      by Zacks Equity Research

      Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

      DVA vs. CHE: Which Stock Should Value Investors Buy Now?

      by Zacks Equity Research

      DVA vs. CHE: Which Stock Is the Better Value Option?

      Is DaVita (DVA) Outperforming Other Medical Stocks This Year?

      by Zacks Equity Research

      Is (DVA) Outperforming Other Medical Stocks This Year?

      DaVita (DVA) Earnings and Revenues Beat Estimates in Q1

      by Zacks Equity Research

      DaVita's (DVA) dialysis services in the United States showcased solid results in Q1.

      DaVita HealthCare (DVA) Surpasses Q1 Earnings and Revenue Estimates

      by Zacks Equity Research

      DaVita HealthCare (DVA) delivered earnings and revenue surprises of 25.34% and 0.17%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

      What's in the Cards for DaVita (DVA)This Earnings Season?

      by Zacks Equity Research

      DaVita (DVA) is expected to have gained from Kidney Care segment in Q1.

      DaVita HealthCare (DVA) Reports Next Week: Wall Street Expects Earnings Growth

      by Zacks Equity Research

      DaVita HealthCare (DVA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

      Zacks.com featured highlights include: DaVita, EchoStar and PennyMac Financial Services

      by Zacks Equity Research

      Zacks.com featured highlights include: DaVita, EchoStar and PennyMac Financial Services

      Should Value Investors Buy DaVita HealthCare (DVA) Stock?

      by Zacks Equity Research

      Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

      The Zacks Analyst Blog Highlights: InMode, Integer, Cardinal Health, DaVita and The Ensign Group

      by Zacks Equity Research

      The Zacks Analyst Blog Highlights: InMode, Integer, Cardinal Health, DaVita and The Ensign Group

      3 Momentum Anomaly Stocks to Consider Amid Coronavirus Woes

      by Zacks Equity Research

      These fast movers are currently witnessing a short-term pullback in price as COVID-19 pandemonium batters market. So, this could essentially be a solid entry point for garnering profits.

      Sejuti Banerjea headshot

      5 Stocks to Buy for 5 Good Reasons

      by Sejuti Banerjea

      Here are 5 ways to make the most of a difficult market.

      The Zacks Analyst Blog Highlights: DVA, CAH, TGNA, SLM and AMX

      by Zacks Equity Research

      The Zacks Analyst Blog Highlights: DVA, CAH, TGNA, SLM and AMX

      Coronavirus-Led Volatility Rises: 5 High Earnings Yield Picks

      by Zacks Equity Research

      Dodge the COVID-19 pandemic by investing in these high earnings yield stocks.